Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Human MYC/bHLHe39/c-Myc ORF/cDNA clone-Lentivirus particle (NM_002467.5)
Cat. No.: vGMLV000287
Pre-made Human MYC/bHLHe39/c-Myc Lentiviral expression plasmid for MYC lentivirus packaging, MYC lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
MYC/c-MYC/MYC/bHLHe39 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
MSDS
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLV000287 | Human MYC Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLV000287 |
| Gene Name | MYC |
| Accession Number | NM_002467.5 |
| Gene ID | 4609 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 1365 bp |
| Gene Alias | bHLHe39,c-Myc,MRTL,MYCC |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | CTGGATTTTTTTCGGGTAGTGGAAAACCAGCAGCCTCCCGCGACGATGCCCCTCAACGTTAGCTTCACCAACAGGAACTATGACCTCGACTACGACTCGGTGCAGCCGTATTTCTACTGCGACGAGGAGGAGAACTTCTACCAGCAGCAGCAGCAGAGCGAGCTGCAGCCCCCGGCGCCCAGCGAGGATATCTGGAAGAAATTCGAGCTGCTGCCCACCCCGCCCCTGTCCCCTAGCCGCCGCTCCGGGCTCTGCTCGCCCTCCTACGTTGCGGTCACACCCTTCTCCCTTCGGGGAGACAACGACGGCGGTGGCGGGAGCTTCTCCACGGCCGACCAGCTGGAGATGGTGACCGAGCTGCTGGGAGGAGACATGGTGAACCAGAGTTTCATCTGCGACCCGGACGACGAGACCTTCATCAAAAACATCATCATCCAGGACTGTATGTGGAGCGGCTTCTCGGCCGCCGCCAAGCTCGTCTCAGAGAAGCTGGCCTCCTACCAGGCTGCGCGCAAAGACAGCGGCAGCCCGAACCCCGCCCGCGGCCACAGCGTCTGCTCCACCTCCAGCTTGTACCTGCAGGATCTGAGCGCCGCCGCCTCAGAGTGCATCGACCCCTCGGTGGTCTTCCCCTACCCTCTCAACGACAGCAGCTCGCCCAAGTCCTGCGCCTCGCAAGACTCCAGCGCCTTCTCTCCGTCCTCGGATTCTCTGCTCTCCTCGACGGAGTCCTCCCCGCAGGGCAGCCCCGAGCCCCTGGTGCTCCATGAGGAGACACCGCCCACCACCAGCAGCGACTCTGAGGAGGAACAAGAAGATGAGGAAGAAATCGATGTTGTTTCTGTGGAAAAGAGGCAGGCTCCTGGCAAAAGGTCAGAGTCTGGATCACCTTCTGCTGGAGGCCACAGCAAACCTCCTCACAGCCCACTGGTCCTCAAGAGGTGCCACGTCTCCACACATCAGCACAACTACGCAGCGCCTCCCTCCACTCGGAAGGACTATCCTGCTGCCAAGAGGGTCAAGTTGGACAGTGTCAGAGTCCTGAGACAGATCAGCAACAACCGAAAATGCACCAGCCCCAGGTCCTCGGACACCGAGGAGAATGTCAAGAGGCGAACACACAACGTCTTGGAGCGCCAGAGGAGGAACGAGCTAAAACGGAGCTTTTTTGCCCTGCGTGACCAGATCCCGGAGTTGGAAAACAATGAAAAGGCCCCCAAGGTAGTTATCCTTAAAAAAGCCACAGCATACATCCTGTCCGTCCAAGCAGAGGAGCAAAAGCTCATTTCTGAAGAGGACTTGTTGCGGAAACGACGAGAACAGTTGAAACACAAACTTGAACAGCTACGGAACTCTTGTGCGTAA |
| ORF Protein Sequence | MDFFRVVENQQPPATMPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAPSEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMVTELLGGDMVNQSFICDPDDETFIKNIIIQDCMWSGFSAAAKLVSEKLASYQAARKDSGSPNPARGHSVCSTSSLYLQDLSAAASECIDPSVVFPYPLNDSSSPKSCASQDSSAFSPSSDSLLSSTESSPQGSPEPLVLHEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKRSESGSPSAGGHSKPPHSPLVLKRCHVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLRQISNNRKCTSPRSSDTEENVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILSVQAEEQKLISEEDLLRKRREQLKHKLEQLRNSCA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T36121-Ab | Anti-MYC monoclonal antibody |
| Target Antigen | GM-Tg-g-T36121-Ag | MYC protein |
| ORF Viral Vector | pGMLV000287 | Human MYC Lentivirus plasmid |
| ORF Viral Vector | pGMLV000288 | Human MYC Lentivirus plasmid |
| ORF Viral Vector | pGMLV000614 | Human MYC Lentivirus plasmid |
| ORF Viral Vector | pGMLV002221 | Human MYC Lentivirus plasmid |
| ORF Viral Vector | pGMAD000804 | Human MYC Adenovirus plasmid |
| ORF Viral Vector | pGMAD001431 | Human MYC Adenovirus plasmid |
| ORF Viral Vector | pGMAP000557 | Human MYC Adenovirus plasmid |
| ORF Viral Vector | pGMPC000377 | Human MYC Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLV000287 | Human MYC Lentivirus particle |
| ORF Viral Vector | vGMLV000288 | Human MYC Lentivirus particle |
| ORF Viral Vector | vGMLV000614 | Human MYC Lentivirus particle |
| ORF Viral Vector | vGMLV002221 | Human MYC Lentivirus particle |
| ORF Viral Vector | vGMAD000804 | Human MYC Adenovirus particle |
| ORF Viral Vector | vGMAD001431 | Human MYC Adenovirus particle |
| ORF Viral Vector | vGMAP000557 | Human MYC Adenovirus particle |
Target information
| Target ID | GM-T36121 |
| Target Name | MYC/c-MYC |
|
Gene Group Identifier （Target Gene ID in Homo species) |
4609 |
| Gene ID |
100068097 (Equus caballus), 100379628 (Felis catus), 17869 (Mus musculus), 24577 (Rattus norvegicus) 403924 (Canis lupus familiaris), 4609 (Homo sapiens), 511077 (Bos taurus), 694626 (Macaca mulatta) |
| Gene Symbols & Synonyms | MYC,Myc,Myc2,Nird,Niard,bHLHe39,mMyc,c-myc,RNCMYC,MRTL,MYCC,C-MYC,v-myc,c-Myc,CMYC |
| Target Alternative Names | MYC, c-MYC,Myc proto-oncogene protein,Class E basic helix-loop-helix protein 39 (bHLHe39), Proto-oncogene c-Myc, Transcription factor p64,MRTL,MYCC,c-Myc,bHLHe39 |
| Uniprot Accession |
B8XIA5,P01106,P01108,P09416,P68271,Q28350,Q2HJ27
Additional SwissProt Accessions: P68271,P01108,P09416,Q28350,P01106,Q2HJ27,B8XIA5 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer, Breast Cancer, Lung Cancer, Lung cancer |
| Disease from KEGG | MAPK signaling pathway, ErbB signaling pathway, PI3K-Akt signaling pathway, Cellular senescence, Wnt signaling pathway, TGF-beta signaling pathway, Hippo signaling pathway, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Thyroid hormone signaling pathway, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Epstein-Barr virus infection, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Colorectal cancer, Endometrial cancer, Thyroid cancer, Bladder cancer, Chronic myeloid leukemia, Acute myeloid leukemia, Small cell lung cancer, Breast cancer, Hepatocellular carcinoma, Gastric cancer, Central carbon metabolism in cancer |
| Gene Ensembl | ENSECAG00000022059, ENSMUSG00000022346, ENSCAFG00845012475, ENSG00000136997, ENSBTAG00000008409, ENSMMUG00000014601 |
| Target Classification | Pathway |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.